RecruitingNCT05205343

Trans-Pacific Multicenter Collaborative Study of Minimally Invasive Proximal Versus Total Gastrectomy for Proximal Gastric and Gastroesophageal Junction Cancers

Sponsor

M.D. Anderson Cancer Center

Enrollment

20 participants

Start Date

May 11, 2022

Study Type

OBSERVATIONAL

Conditions

To compare the symptoms of patients who have a MIPG to the symptoms of patients who have a MITG.

Min Age: 18 Years

Able to speak and read English, Spanish, Japanese or Korean
Participants with a biopsy-confirmed diagnosis of non-metastatic gastric or GEJ adenocarcinoma, who are scheduled to undergo MIPG or MITG for curative-intention
Age ≥ 18

Participants with known malabsorption syndromes or a lack of physical integrity of the upper gastrointestinal tract
Participants with known narcotic dependence, with average daily dose \> 5 mg oral morphine equivalent
Participants deemed unable to comply with study and/or follow-up procedures, at investigators' discretion
Participants who are pregnant (since are excluded from receiving standard-of-care MIPG or MITG)

OTHERStandard of Care

complete a questionnaire within 30 days before your surgery and then at 1, 3, 6, and 12 months after surgery

OTHERControl Group

complete a questionnaire within 30 days before your surgery and then at 1, 3, 6, and 12 months after surgery

Mayo Clinic in Rochester

Rochester, Minnesota, United States

M D Anderson Cancer Center

Houston, Texas, United States

Keio University School of Medicine

Tokyo, Japan

Yonsei University College of Medicine

Soeul, South Korea

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

NCT05205343